Many patients begin noticing symptom improvement within a few days to a few weeks after PAE
This carryover effect makes the three-month pause more manageable than restarting from baseline
1B, left panel)
Explorations #2: The RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide by Cort Johnson | Apr 6, 2026 | Abilify, Antivirals, Baricitinib, Bezisterim, CCR5 Antagonists, Drugs, GLP-1, Guanfacine, Homepage, Ivabradine, IVIG, JAK_STAT Inhibitors, Low Dose Naltrexone, Mestinon, Rapamycin, Stellate Ganglion Block, Stimulants, Trazodone, Treatment Check out the The free RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide and why we may FDA approved drugs for long COVID quicker than you might think
Accordingly, rifaximin is recognized as the second most commonly used therapeutic agent for the treatment of CHE, following lactulose [8]
The program cost is $299 for our new patients